SCHEMBL8554870

SCHEMBL8554870

CCn1cc(C(=O)O)c(=O)c2c(C)c(F)c(N3CCNCC3)cc21

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 7/20 0.68
KDM4E B2RXH2 7/20 0.68
ALDH1A1 P00352 7/20 0.68
HPGD P15428 7/20 0.68
LMNA P02545 5/20 0.68
TSHR P16473 2/20 0.68
HTT P42858 2/20 0.68
BRD4 O60885 1/20 0.68
CYP2J2 P51589 1/20 0.68
NPSR1 Q6W5P4 1/20 0.68
KCNH2 Q12809 1/20 0.55
HRH3 Q9Y5N1 1/20 0.55
DRD3 P35462 1/20 0.53
CYP2C9 P11712 2/20 0.52
ATP6V1B2 P21281 1/20 0.52
TBXA2R P21731 1/20 0.52
EDNRA P25101 1/20 0.52
TARBP2 Q15633 1/20 0.52
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9088353 0.87 KCNH2 (0.74) HSD17B10KDM4EALDH1A1HPGDLMNA
SCHEMBL10415768 0.84 KCNH2 (0.58) HSD17B10KDM4EALDH1A1HPGDLMNA
SCHEMBL8554680 0.82 KCNH2 (0.79) HSD17B10KDM4EALDH1A1HPGDLMNA
SCHEMBL9086828 0.82 KCNH2 (0.54) HSD17B10KDM4EALDH1A1HPGDLMNA
Hydrochloric Acid SCHEMBL8111805 0.81 KCNH2 (0.54) HSD17B10KDM4EALDH1A1HPGDLMNA
Norfloxacin SCHEMBL2221304 0.81 ALDH1A1 (1.00) HSD17B10KDM4EALDH1A1HPGDLMNA
Norfloxacin SCHEMBL27395494 0.81 ALDH1A1 (1.00) HSD17B10KDM4EALDH1A1HPGDLMNA
SCHEMBL8558484 0.81 KDM4E (0.53) HSD17B10KDM4EALDH1A1HPGDLMNA
Norfloxacin SCHEMBL3473 0.81 ALDH1A1 (1.00) HSD17B10KDM4EALDH1A1HPGDLMNA
SCHEMBL8558767 0.81 LMNA (0.67) HSD17B10KDM4EALDH1A1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811576-A 1-CARBOXY-2-LOWERALKYL-3,4,6-TRI(HALO)BENZENES; GRAMPOSITIVE AND-NEGATIVE BACTERIA; INFECTIONS; STERILIZATION OF MEDICAL EQUIPMENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1998-09-22 US disclosed
US-5723648-A Intermediates for anti-microbial benzoheterocyclic compounds OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1998-03-03 US disclosed
EP-0823413-A2 Benzoheterocyclic compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1998-02-11 EP disclosed
US-5585491-A Antibacterial agents OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1996-12-17 US disclosed
US-5563138-A 4-OXOQUINOLINE-3-CARBOXYLIC ACID COMPOUNDS HAVING ANTIMICROBIAL ACTIVITY OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1996-10-08 US disclosed
EP-0287951-B1 7-Piperazinyl- or 7-Morpholino-4-oxo-quinoline-3-carboxylic acid derivatives, their preparation and their use as antimicrobial agents OTSUKA PHARMA CO LTD (JP) 1996-07-03 EP disclosed
US-5290934-A Benzoheterocyclic compounds OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1994-03-01 US disclosed
EP-0565132-A2 Benzoheterocyclic compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-10-13 EP disclosed
EP-0398967-A1 ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1990-11-28 EP disclosed
US-4920120-A 3-CARBOXY, 4-OXO, 6-FLUORO, 7-NITROGEN-CONTAINING RING 1,4-DIHYDRO-1,8-NAPHTHYRIDINES WARNER-LAMBERT COMPANY (US) 1990-04-24 US disclosed
WO-1989006649-A2 ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1989-07-27 WO disclosed
EP-0287951-A2 7-Piperazinyl- or 7-Morpholino-4-oxo-quinoline-3-carboxylic acid derivatives, their preparation and their use as antimicrobial agents OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1988-10-26 EP disclosed